-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Galmed Pharmaceuticals Ltd. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
- Galmed Pharmaceuticals Ltd. Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.18 USD/shares, a 81.1% decline year-over-year.
- Galmed Pharmaceuticals Ltd. annual Earnings Per Share, Basic for 2023 was 2.5 USD/shares, a 76.5% decline from 2022.
- Galmed Pharmaceuticals Ltd. annual Earnings Per Share, Basic for 2022 was 10.7 USD/shares, a 46.2% decline from 2021.
- Galmed Pharmaceuticals Ltd. annual Earnings Per Share, Basic for 2021 was 19.8 USD/shares, a 1367% increase from 2020.
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)